DSM pharmaceuticals to double sterile manufacturing capacity

DSM pharmaceuticals to double sterile manufacturing capacity
Russell, Ronelle
2/1/2003
Pharmaceutical Technology
In response to steadily increasing demand, DSM Pharmaceuticals (Greenville, NC) is investing $62 million in the expansion of its sterile manufacturing capacity. By adding five new, state-of-the-art freeze dryers and one new filling line to its Greenville site, the company expects to more than double its current lyophilization capacity by 2004.
Kevin Lesnewski, DSM's senior manager of marketing and business intelligence, sees the market for sterile products growing at a double-digit rate, a figure that doesn't include potential biological products already in the drug pipeline. ...
Read the Full Article, Get a FREE Trial for instant access ?